# Roblox Corp: financial statements, quarterly

RBLX · NYSE · CIK 1315098 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rblx.md) · [Financials](/companies/rblx/financials.md) · [Filings](/companies/rblx/filings.md) · [Insiders](/companies/rblx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rblx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [750 d](/filings/0001315098-26-000024.md) | [801](/filings/0001315098-25-000118.md) | [894](/filings/0001315098-25-000262.md) | [919](/filings/0001315098-25-000327.md) | [988 d](/filings/0001315098-26-000024.md) | [1,035](/filings/0001628280-26-028904.md) | [1,081](/filings/0001628280-26-051082.md) | [1,360](/filings/0001628280-26-068253.md) | [1,415 d](/filings/0001315098-26-000024.md) | [1,442](/filings/0001628280-26-028904.md) | [1,469](/filings/0001628280-26-051082.md) | [1,572](/filings/0001628280-26-068253.md) |
| Cost of revenue | $m | [172 d](/filings/0001315098-26-000024.md) | [179](/filings/0001315098-25-000118.md) | [199](/filings/0001315098-25-000262.md) | [205](/filings/0001315098-25-000327.md) | [219 d](/filings/0001315098-26-000024.md) | [225](/filings/0001628280-26-028904.md) | [236](/filings/0001628280-26-051082.md) | [296](/filings/0001628280-26-068253.md) | [315 d](/filings/0001315098-26-000024.md) | [294](/filings/0001628280-26-028904.md) | [292](/filings/0001628280-26-051082.md) | [318](/filings/0001628280-26-068253.md) |
| Research and development | $m | [341 d](/filings/0001315098-26-000024.md) | [362](/filings/0001315098-25-000118.md) | [362](/filings/0001315098-25-000262.md) | [365](/filings/0001315098-25-000327.md) | [355 d](/filings/0001315098-26-000024.md) | [374](/filings/0001628280-26-028904.md) | [385](/filings/0001628280-26-051082.md) | [399](/filings/0001628280-26-068253.md) | [410 d](/filings/0001315098-26-000024.md) | [422](/filings/0001628280-26-028904.md) | [420](/filings/0001628280-26-051082.md) | [435](/filings/0001628280-26-068253.md) |
| Operating income | $m | [(355) d](/filings/0001315098-26-000024.md) | [(302)](/filings/0001315098-25-000118.md) | [(238)](/filings/0001315098-25-000262.md) | [(279)](/filings/0001315098-25-000327.md) | [(244) d](/filings/0001315098-26-000024.md) | [(255)](/filings/0001628280-26-028904.md) | [(322)](/filings/0001628280-26-051082.md) | [(296)](/filings/0001628280-26-068253.md) | [(359) d](/filings/0001315098-26-000024.md) | [(294)](/filings/0001628280-26-028904.md) | [(229)](/filings/0001628280-26-051082.md) | [(283)](/filings/0001628280-26-068253.md) |
| Interest expense | $m | [10.3 d](/filings/0001315098-24-000026.md) | [10.4](/filings/0001315098-24-000095.md) | [10.2](/filings/0001315098-25-000262.md) | [10.3](/filings/0001315098-25-000327.md) | [10.3 d](/filings/0001315098-26-000024.md) | [10.0](/filings/0001628280-26-028904.md) | [11.0](/filings/0001628280-26-051082.md) | [10.0](/filings/0001628280-26-068253.md) | [10.5 d](/filings/0001315098-26-000024.md) | [10.0](/filings/0001628280-26-028904.md) | [10.0](/filings/0001628280-26-051082.md) | [11.0](/filings/0001628280-26-068253.md) |
| Income tax | $m | [0.3 d](/filings/0001315098-26-000024.md) | [1.1](/filings/0001315098-25-000118.md) | [0.1](/filings/0001315098-25-000262.md) | [0.3](/filings/0001315098-25-000327.md) | [2.6 d](/filings/0001315098-26-000024.md) | [1.0](/filings/0001628280-26-028904.md) | [1.0](/filings/0001628280-26-051082.md) | [1.0](/filings/0001628280-26-068253.md) | [0.6 d](/filings/0001315098-26-000024.md) | [1.0](/filings/0001628280-26-028904.md) | [2.0](/filings/0001628280-26-051082.md) | [1.0](/filings/0001628280-26-068253.md) |
| Net income | $m | [(324) d](/filings/0001315098-26-000024.md) | [(271)](/filings/0001315098-25-000118.md) | [(206)](/filings/0001315098-25-000262.md) | [(239)](/filings/0001315098-25-000327.md) | [(220) d](/filings/0001315098-26-000024.md) | [(215)](/filings/0001628280-26-028904.md) | [(278)](/filings/0001628280-26-051082.md) | [(256)](/filings/0001628280-26-068253.md) | [(316) d](/filings/0001315098-26-000024.md) | [(246)](/filings/0001628280-26-028904.md) | [(183)](/filings/0001628280-26-051082.md) | [(227)](/filings/0001628280-26-068253.md) |
| Diluted EPS | $ per share | not reported | [(0.43)](/filings/0001315098-25-000118.md) | [(0.32)](/filings/0001315098-25-000262.md) | [(0.37)](/filings/0001315098-25-000327.md) | not reported | [(0.32)](/filings/0001628280-26-028904.md) | [(0.41)](/filings/0001628280-26-051082.md) | [(0.37)](/filings/0001628280-26-068253.md) | not reported | [(0.35)](/filings/0001628280-26-028904.md) | [(0.26)](/filings/0001628280-26-051082.md) | [(0.32)](/filings/0001628280-26-068253.md) |
| Basic EPS | $ per share | not reported | [(0.43)](/filings/0001315098-25-000118.md) | [(0.32)](/filings/0001315098-25-000262.md) | [(0.37)](/filings/0001315098-25-000327.md) | not reported | [(0.32)](/filings/0001628280-26-028904.md) | [(0.41)](/filings/0001628280-26-051082.md) | [(0.37)](/filings/0001628280-26-068253.md) | not reported | [(0.35)](/filings/0001628280-26-028904.md) | [(0.26)](/filings/0001628280-26-051082.md) | [(0.32)](/filings/0001628280-26-068253.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.7](/filings/0001315098-25-000033.md) | [0.9](/filings/0001315098-24-000095.md) | [1.0](/filings/0001315098-24-000166.md) | [0.6](/filings/0001315098-24-000250.md) | [0.7](/filings/0001315098-26-000024.md) | [1.2](/filings/0001315098-25-000118.md) | [1.0](/filings/0001315098-25-000262.md) | [1.0](/filings/0001315098-25-000327.md) | [1.2](/filings/0001628280-26-068253.md) | [1.2](/filings/0001628280-26-028904.md) | [1.0](/filings/0001628280-26-051082.md) | [1.1](/filings/0001628280-26-068253.md) |
| Current assets | $bn | [3.3](/filings/0001315098-25-000033.md) | [3.4](/filings/0001315098-24-000095.md) | [3.4](/filings/0001315098-24-000166.md) | [3.4](/filings/0001315098-24-000250.md) | [3.7](/filings/0001315098-26-000024.md) | [3.9](/filings/0001315098-25-000118.md) | [3.9](/filings/0001315098-25-000262.md) | [4.4](/filings/0001315098-25-000327.md) | [4.9](/filings/0001628280-26-068253.md) | [4.7](/filings/0001628280-26-028904.md) | [4.5](/filings/0001628280-26-051082.md) | [4.7](/filings/0001628280-26-068253.md) |
| Total assets | $bn | [6.2](/filings/0001315098-25-000033.md) | [6.3](/filings/0001315098-24-000095.md) | [6.5](/filings/0001315098-24-000166.md) | [6.7](/filings/0001315098-24-000250.md) | [7.2](/filings/0001315098-26-000024.md) | [7.5](/filings/0001315098-25-000118.md) | [7.8](/filings/0001315098-25-000262.md) | [8.6](/filings/0001315098-25-000327.md) | [9.6](/filings/0001628280-26-068253.md) | [9.8](/filings/0001628280-26-028904.md) | [9.7](/filings/0001628280-26-051082.md) | [10.0](/filings/0001628280-26-068253.md) |
| Current liabilities | $bn | [3.1](/filings/0001315098-25-000033.md) | [3.1](/filings/0001315098-24-000095.md) | [3.3](/filings/0001315098-24-000166.md) | [3.4](/filings/0001315098-24-000250.md) | [3.7](/filings/0001315098-26-000024.md) | [3.8](/filings/0001315098-25-000118.md) | [4.1](/filings/0001315098-25-000262.md) | [4.5](/filings/0001315098-25-000327.md) | [5.1](/filings/0001628280-26-068253.md) | [5.3](/filings/0001628280-26-028904.md) | [5.5](/filings/0001628280-26-051082.md) | [5.9](/filings/0001628280-26-068253.md) |
| Total liabilities | $bn | [6.1](/filings/0001315098-25-000033.md) | [6.3](/filings/0001315098-24-000095.md) | [6.4](/filings/0001315098-24-000166.md) | [6.5](/filings/0001315098-24-000250.md) | [7.0](/filings/0001315098-26-000024.md) | [7.2](/filings/0001315098-25-000118.md) | [7.5](/filings/0001315098-25-000262.md) | [8.2](/filings/0001315098-25-000327.md) | [9.2](/filings/0001628280-26-068253.md) | [9.4](/filings/0001628280-26-028904.md) | [9.6](/filings/0001628280-26-051082.md) | [10.1](/filings/0001628280-26-068253.md) |
| Long-term debt | $bn | [1.0](/filings/0001315098-25-000033.md) | [1.0](/filings/0001315098-24-000095.md) | [1.0](/filings/0001315098-24-000166.md) | [1.0](/filings/0001315098-24-000250.md) | [1.0](/filings/0001315098-26-000024.md) | [1.0](/filings/0001315098-25-000118.md) | [1.0](/filings/0001315098-25-000262.md) | [1.0](/filings/0001315098-25-000327.md) | [1.0](/filings/0001628280-26-068253.md) | [1.0](/filings/0001628280-26-028904.md) | [1.0](/filings/0001628280-26-051082.md) | [1.0](/filings/0001628280-26-068253.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | [0.0](/filings/0001315098-26-000024.md) | not reported | [0.0](/filings/0001315098-25-000262.md) | [0.0](/filings/0001315098-25-000327.md) | [0.0](/filings/0001628280-26-068253.md) | [0.0](/filings/0001628280-26-028904.md) | [0.0](/filings/0001628280-26-051082.md) | [0.0](/filings/0001628280-26-068253.md) |
| Shareholders' equity | $bn | [0.1](/filings/0001315098-25-000033.md) | [0.1](/filings/0001315098-24-000095.md) | [0.1](/filings/0001315098-24-000166.md) | [0.2](/filings/0001315098-24-000250.md) | [0.2](/filings/0001315098-26-000024.md) | [0.3](/filings/0001315098-25-000118.md) | [0.4](/filings/0001315098-25-000262.md) | [0.4](/filings/0001315098-25-000327.md) | [0.4](/filings/0001628280-26-068253.md) | [0.4](/filings/0001628280-26-028904.md) | [0.2](/filings/0001628280-26-051082.md) | [(0.0)](/filings/0001628280-26-068253.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [143 d](/filings/0001315098-26-000024.md) | [239](/filings/0001315098-25-000118.md) | [151 d](/filings/0001315098-25-000262.md) | [247 d](/filings/0001315098-25-000327.md) | [184 d](/filings/0001315098-26-000024.md) | [444](/filings/0001628280-26-028904.md) | [199 d](/filings/0001628280-26-051082.md) | [546 d](/filings/0001628280-26-068253.md) | [607 d](/filings/0001315098-26-000024.md) | [629](/filings/0001628280-26-028904.md) | [318 d](/filings/0001628280-26-051082.md) | [395 d](/filings/0001628280-26-068253.md) |
| Capital expenditure | $m | [65.2 d](/filings/0001315098-26-000024.md) | [46.7](/filings/0001315098-25-000118.md) | [39.7 d](/filings/0001315098-25-000262.md) | [29.4 d](/filings/0001315098-25-000327.md) | [63.9 d](/filings/0001315098-26-000024.md) | [17.0](/filings/0001628280-26-028904.md) | [23.0 d](/filings/0001628280-26-051082.md) | [103 d](/filings/0001628280-26-068253.md) | [298 d](/filings/0001315098-26-000024.md) | [33.0](/filings/0001628280-26-028904.md) | [22.0 d](/filings/0001628280-26-051082.md) | [28.0 d](/filings/0001628280-26-068253.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001628280-26-068253.md) | not reported | not reported | not reported | [201 d](/filings/0001628280-26-068253.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [607](/filings/0001315098-24-000095.md) | [613](/filings/0001315098-24-000166.md) | [619](/filings/0001315098-24-000250.md) | [635](/filings/0001315098-25-000118.md) | [643](/filings/0001315098-25-000262.md) | [651](/filings/0001315098-25-000327.md) | [672](/filings/0001628280-26-028904.md) | [685](/filings/0001628280-26-051082.md) | [697](/filings/0001628280-26-068253.md) | [712](/filings/0001628280-26-028904.md) | [717](/filings/0001628280-26-051082.md) | [716](/filings/0001628280-26-068253.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:08 ET. No prices; not investment advice.